| Modality | Indication | Current Stage | Development Partners | ||||
|---|---|---|---|---|---|---|---|
| Discovery | Pre-clinical | Phase 1 | Phase 2 | Phase 3 | |||
| Cancer | |||||||
| Vaccine | Breast Cancer |
|
|
|
|
||
| Vaccine | Ovarian Cancer |
|
|
|
|||
| Vaccine | Lung, Colon, and Prostate Cancers |
|
|
||||
| CAR-T | Ovarian Cancer |
|
|
|
|
||
| CAR-T | Other solid tumors |
|
|
||||
Latest News & Events
Anixa Biosciences Announces Approval of Protocol Amendment for Ovarian Cancer CAR-T Clinical Trial
Read More...Anixa Biosciences Chairman and CEO Discusses Pioneering CAR-T Cell Therapy and Breast Cancer Vaccine in Alpha Wolf Trading Interview
Read More...Anixa Biosciences to Present at the 18th Annual European Life Sciences CEO Forum
Read More...